Trials / Completed
CompletedNCT02630914
Medical and Surgical Hybrid Treatment of Atrial Fibrillation.
Medical and Surgical Hybrid Treatment of Atrial Fibrillation: Epicardial and Endocardial Combined Approach.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to investigate the feasibility of a hybrid procedure removal of the atrial fibrillation. This is a single procedure for both surgical epicardial by minimally invasive route (Thoracoscopy) without even flow controlled and supplemented if necessary by extra corporeal intracavitary route at the same time. This faster procedure combined with complete lesions have a higher success rate and less frequent re-hospitalizations of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The AtriCure Synergy Ablation System | The AtriCure Synergy Ablation System will be used on all patients for AF ablation. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2015-12-15
- Last updated
- 2025-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02630914. Inclusion in this directory is not an endorsement.